Enhanced apoptosis in pilocytic astrocytoma: A comparative study of apoptosis and proliferation in astrocytic tumors

Akira Nakamizo, Takanori Inamura, Kiyonobu Ikezaki, Koji Yoshimoto, Satoshi Inoha, Masahiro Mizoguchi, Toshiyuki Amano, Masashi Fukui

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Both cell proliferation and cell death occur simultaneously in tumor tissue, and extent of tumor growth reflects the net balance of these events. We correlated cell proliferation, spontaneous cell death, and alterations in tumor suppressor proteins with one another and with survival of patients with primary astrocytic tumors. In 39 astrocytic tumor specimens (6 pilocytic astrocytomas, 14 fibrillary astrocytomas, 9 anaplastic astrocytomas, and 10 glioblastomas), we determined the MIB-1 labeling index, the apoptotic ratio according to nick end labeling with morphologic confirmation, the p53 labeling index, and the presence of p53 or PTEN mutations. MIB-1 labeling indices of pilocytic astrocytomas, fibrillary astrocytomas, anaplastic astrocytomas, and glioblastomas were 0.30 ± 0.32; 1.84 ± 1.87; 19.3 ± 6.42; and 28.0 ± 14.5 (mean ± SD), respectively. Corresponding apoptotic ratios were 17.9 ± 5.16; 3.96 ± 3.57; 1.18 ± 0.93; and 2.11 ± 1.60 (mean ± SD). The apoptotic ratio in pilocytic astrocytomas was significantly higher than in other astrocytic tumors (fibrillary astrocytomas, p < 0.05; anaplastic astrocytomas and glioblastomas, p < 0.01). MIB-1 showed a significant negative correlation with apoptosis (p < 0.01). MIB-1 and apoptosis showed significant negative and positive correlations with patient survival (p < 0.01). Mutations of p53 and PTEN show no correlation with survival and apoptotic ratio. The apoptotic ratio can clearly distinguish pilocytic astrocytomas from other tumors, and this biological feature may reflect less aggressive growth of pilocytic astrocytomas.

Original languageEnglish
Pages (from-to)105-114
Number of pages10
JournalJournal of Neuro-Oncology
Volume57
Issue number2
DOIs
Publication statusPublished - Jul 8 2002

Fingerprint

Astrocytoma
Apoptosis
Neoplasms
Glioblastoma
Survival
Cell Death
Cell Proliferation
Tumor Suppressor Proteins
Mutation
Growth

All Science Journal Classification (ASJC) codes

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Enhanced apoptosis in pilocytic astrocytoma : A comparative study of apoptosis and proliferation in astrocytic tumors. / Nakamizo, Akira; Inamura, Takanori; Ikezaki, Kiyonobu; Yoshimoto, Koji; Inoha, Satoshi; Mizoguchi, Masahiro; Amano, Toshiyuki; Fukui, Masashi.

In: Journal of Neuro-Oncology, Vol. 57, No. 2, 08.07.2002, p. 105-114.

Research output: Contribution to journalArticle

Nakamizo, Akira ; Inamura, Takanori ; Ikezaki, Kiyonobu ; Yoshimoto, Koji ; Inoha, Satoshi ; Mizoguchi, Masahiro ; Amano, Toshiyuki ; Fukui, Masashi. / Enhanced apoptosis in pilocytic astrocytoma : A comparative study of apoptosis and proliferation in astrocytic tumors. In: Journal of Neuro-Oncology. 2002 ; Vol. 57, No. 2. pp. 105-114.
@article{57887ea57a86435f84b567e0ca5cb38e,
title = "Enhanced apoptosis in pilocytic astrocytoma: A comparative study of apoptosis and proliferation in astrocytic tumors",
abstract = "Both cell proliferation and cell death occur simultaneously in tumor tissue, and extent of tumor growth reflects the net balance of these events. We correlated cell proliferation, spontaneous cell death, and alterations in tumor suppressor proteins with one another and with survival of patients with primary astrocytic tumors. In 39 astrocytic tumor specimens (6 pilocytic astrocytomas, 14 fibrillary astrocytomas, 9 anaplastic astrocytomas, and 10 glioblastomas), we determined the MIB-1 labeling index, the apoptotic ratio according to nick end labeling with morphologic confirmation, the p53 labeling index, and the presence of p53 or PTEN mutations. MIB-1 labeling indices of pilocytic astrocytomas, fibrillary astrocytomas, anaplastic astrocytomas, and glioblastomas were 0.30 ± 0.32; 1.84 ± 1.87; 19.3 ± 6.42; and 28.0 ± 14.5 (mean ± SD), respectively. Corresponding apoptotic ratios were 17.9 ± 5.16; 3.96 ± 3.57; 1.18 ± 0.93; and 2.11 ± 1.60 (mean ± SD). The apoptotic ratio in pilocytic astrocytomas was significantly higher than in other astrocytic tumors (fibrillary astrocytomas, p < 0.05; anaplastic astrocytomas and glioblastomas, p < 0.01). MIB-1 showed a significant negative correlation with apoptosis (p < 0.01). MIB-1 and apoptosis showed significant negative and positive correlations with patient survival (p < 0.01). Mutations of p53 and PTEN show no correlation with survival and apoptotic ratio. The apoptotic ratio can clearly distinguish pilocytic astrocytomas from other tumors, and this biological feature may reflect less aggressive growth of pilocytic astrocytomas.",
author = "Akira Nakamizo and Takanori Inamura and Kiyonobu Ikezaki and Koji Yoshimoto and Satoshi Inoha and Masahiro Mizoguchi and Toshiyuki Amano and Masashi Fukui",
year = "2002",
month = "7",
day = "8",
doi = "10.1023/A:1015705305540",
language = "English",
volume = "57",
pages = "105--114",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Enhanced apoptosis in pilocytic astrocytoma

T2 - A comparative study of apoptosis and proliferation in astrocytic tumors

AU - Nakamizo, Akira

AU - Inamura, Takanori

AU - Ikezaki, Kiyonobu

AU - Yoshimoto, Koji

AU - Inoha, Satoshi

AU - Mizoguchi, Masahiro

AU - Amano, Toshiyuki

AU - Fukui, Masashi

PY - 2002/7/8

Y1 - 2002/7/8

N2 - Both cell proliferation and cell death occur simultaneously in tumor tissue, and extent of tumor growth reflects the net balance of these events. We correlated cell proliferation, spontaneous cell death, and alterations in tumor suppressor proteins with one another and with survival of patients with primary astrocytic tumors. In 39 astrocytic tumor specimens (6 pilocytic astrocytomas, 14 fibrillary astrocytomas, 9 anaplastic astrocytomas, and 10 glioblastomas), we determined the MIB-1 labeling index, the apoptotic ratio according to nick end labeling with morphologic confirmation, the p53 labeling index, and the presence of p53 or PTEN mutations. MIB-1 labeling indices of pilocytic astrocytomas, fibrillary astrocytomas, anaplastic astrocytomas, and glioblastomas were 0.30 ± 0.32; 1.84 ± 1.87; 19.3 ± 6.42; and 28.0 ± 14.5 (mean ± SD), respectively. Corresponding apoptotic ratios were 17.9 ± 5.16; 3.96 ± 3.57; 1.18 ± 0.93; and 2.11 ± 1.60 (mean ± SD). The apoptotic ratio in pilocytic astrocytomas was significantly higher than in other astrocytic tumors (fibrillary astrocytomas, p < 0.05; anaplastic astrocytomas and glioblastomas, p < 0.01). MIB-1 showed a significant negative correlation with apoptosis (p < 0.01). MIB-1 and apoptosis showed significant negative and positive correlations with patient survival (p < 0.01). Mutations of p53 and PTEN show no correlation with survival and apoptotic ratio. The apoptotic ratio can clearly distinguish pilocytic astrocytomas from other tumors, and this biological feature may reflect less aggressive growth of pilocytic astrocytomas.

AB - Both cell proliferation and cell death occur simultaneously in tumor tissue, and extent of tumor growth reflects the net balance of these events. We correlated cell proliferation, spontaneous cell death, and alterations in tumor suppressor proteins with one another and with survival of patients with primary astrocytic tumors. In 39 astrocytic tumor specimens (6 pilocytic astrocytomas, 14 fibrillary astrocytomas, 9 anaplastic astrocytomas, and 10 glioblastomas), we determined the MIB-1 labeling index, the apoptotic ratio according to nick end labeling with morphologic confirmation, the p53 labeling index, and the presence of p53 or PTEN mutations. MIB-1 labeling indices of pilocytic astrocytomas, fibrillary astrocytomas, anaplastic astrocytomas, and glioblastomas were 0.30 ± 0.32; 1.84 ± 1.87; 19.3 ± 6.42; and 28.0 ± 14.5 (mean ± SD), respectively. Corresponding apoptotic ratios were 17.9 ± 5.16; 3.96 ± 3.57; 1.18 ± 0.93; and 2.11 ± 1.60 (mean ± SD). The apoptotic ratio in pilocytic astrocytomas was significantly higher than in other astrocytic tumors (fibrillary astrocytomas, p < 0.05; anaplastic astrocytomas and glioblastomas, p < 0.01). MIB-1 showed a significant negative correlation with apoptosis (p < 0.01). MIB-1 and apoptosis showed significant negative and positive correlations with patient survival (p < 0.01). Mutations of p53 and PTEN show no correlation with survival and apoptotic ratio. The apoptotic ratio can clearly distinguish pilocytic astrocytomas from other tumors, and this biological feature may reflect less aggressive growth of pilocytic astrocytomas.

UR - http://www.scopus.com/inward/record.url?scp=0035986169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035986169&partnerID=8YFLogxK

U2 - 10.1023/A:1015705305540

DO - 10.1023/A:1015705305540

M3 - Article

C2 - 12125970

AN - SCOPUS:0035986169

VL - 57

SP - 105

EP - 114

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -